Search research articles
Contact Us
Filters
Showing results (1-10 of 125) with videos related to
Page
of 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 2017
Why Targeting of PSMA Is a Valuable Addition to the Management of Castration-Resistant Prostate Cancer: The Urologist's Point of View
Boris A Hadaschik, Martin Boegemann
European Urology
|
August 12, 2022
Re: Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
Claudia Kesch, Boris A Hadaschik
The Journal of Urology
|
September 21, 2013
Editorial comment
Timur H Kuru, Boris A Hadaschik
The Journal of Urology
|
March 22, 2014
Editorial comment
Boris A Hadaschik, Timur H Kuru
European Urology
|
March 21, 2016
Reply to Stephen B. Williams and John F. Ward's Letter to the Editor re: Jan P. Radtke, Constantin Schwab, Maya B. Wolf, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.12.052
Boris A Hadaschik, Jan Philipp Radtke
Urologic Oncology
|
September 11, 2007
Therapeutic options for hormone-refractory prostate cancer in 2007
Boris A Hadaschik, Martin E Gleave
European Urology Focus
|
September 25, 2020
Prostate-specific Membrane Antigen Imaging and Theranostics Impact Patient Outcomes
Boris A Hadaschik, Frederik L Giesel, Kim Chi
International Journal of Urology : Official Journal of the Japanese Urological Association
|
January 15, 2017
Editorial Comment to Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology
Claudia Kesch, Boris A Hadaschik, Jan P Radtke
Current Opinion in Urology
|
April 7, 2007
Novel targets and approaches in advanced prostate cancer
Boris A Hadaschik, Richard D Sowery, Martin E Gleave
European Urology
|
October 13, 2023
A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?
Ulrich Krafft, Boris A Hadaschik, Katharina Lückerath, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 125) with videos related to
Sort By:
Page
of 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 20, 2017
Why Targeting of PSMA Is a Valuable Addition to the Management of Castration-Resistant Prostate Cancer: The Urologist's Point of View
Boris A Hadaschik, Martin Boegemann
European Urology
|
August 12, 2022
Re: Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial
Claudia Kesch, Boris A Hadaschik
The Journal of Urology
|
September 21, 2013
Editorial comment
Timur H Kuru, Boris A Hadaschik
The Journal of Urology
|
March 22, 2014
Editorial comment
Boris A Hadaschik, Timur H Kuru
European Urology
|
March 21, 2016
Reply to Stephen B. Williams and John F. Ward's Letter to the Editor re: Jan P. Radtke, Constantin Schwab, Maya B. Wolf, et al. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.12.052
Boris A Hadaschik, Jan Philipp Radtke
Urologic Oncology
|
September 11, 2007
Therapeutic options for hormone-refractory prostate cancer in 2007
Boris A Hadaschik, Martin E Gleave
European Urology Focus
|
September 25, 2020
Prostate-specific Membrane Antigen Imaging and Theranostics Impact Patient Outcomes
Boris A Hadaschik, Frederik L Giesel, Kim Chi
International Journal of Urology : Official Journal of the Japanese Urological Association
|
January 15, 2017
Editorial Comment to Assessing clinically significant prostate cancer: Diagnostic properties of multiparametric magnetic resonance imaging compared to three-dimensional transperineal template mapping histopathology
Claudia Kesch, Boris A Hadaschik, Jan P Radtke
Current Opinion in Urology
|
April 7, 2007
Novel targets and approaches in advanced prostate cancer
Boris A Hadaschik, Richard D Sowery, Martin E Gleave
European Urology
|
October 13, 2023
A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?
Ulrich Krafft, Boris A Hadaschik, Katharina Lückerath, et al.
Page
of 13